september 14, 2022

Ectin Research to attend Nordic Life Science Days

Ectin Research AB CEO Anna Sjöblom-Hallén will attend the Nordic Life Sciences Days (NLS) event in Malmö, 28 – 29 September. Ectin Research’s novel cancer therapy for metastatic urothelial bladder cancer, MFA-370, is planned to be a simple oral tablet that aims to eliminate tumors safely with few potential side effects.

 Nordic Life Sciences Days attracts leading decision makers from across the pharma, biotech and medtech sectors. To book a meeting at NLSDays with Ectin’s CEO Anna Sjöblom-Hallén go to NLSDays BIO One-on-One Partnering™ or here:

 Mobile: +46 734 30 93 30